Reciprocal regulation of beta-adrenergic receptor mRNA stability by mitogen activated protein kinase activation and inhibition

Molecular and Cellular Biochemistry

Volumn 258, Issue 1-2, 2004, Pages 109-119

  Headley, Violetta V ^a   Tanveer, Rasheeda ^a   Greene, Scott M ^a   Zweifach, Adam ^a   Port, J David ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

AUF1 hnRNP D; Beta adrenergic receptor; HuR; MAP kinase; mRNA binding proteins; mRNA stability

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; BETA ADRENERGIC RECEPTOR; CYTOKINE; G PROTEIN COUPLED RECEPTOR; GENISTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR ALPHA; WORTMANNIN;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; HYPOTHESIS; NONHUMAN; PROTEIN METABOLISM; PROTEIN STABILITY; REGULATORY MECHANISM;

1-PHOSPHATIDYLINOSITOL 3-KINASE; 3' UNTRANSLATED REGIONS; ANIMALS; ANISOMYCIN; ANTHRACENES; BUTADIENES; CELL LINE; CRICETINAE; ENZYME ACTIVATION; ENZYME INHIBITORS; FLAVONOIDS; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; IMIDAZOLES; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NITRILES; NUCLEIC ACID SYNTHESIS INHIBITORS; PYRIDINES; RECEPTORS, ADRENERGIC, BETA; RNA STABILITY; SIGNAL TRANSDUCTION;

EID: 1442281876     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MCBI.0000012841.03400.42     Document Type: Article

References (43)

1. Communal C, Singh K, Sawyer DB, Colucci WS: Opposing effects of beta(1)- and beta(2)-adrenergic receptors on cardiac myocyte apoptosis: Role of a pertussis toxin-sensitive G protein. Circulation 100: 2210-2212, 1999
2. Danner S, Frank M, Lohse MJ: Agonist regulation of human β2-adrenergic receptor mRNA stability occurs via a specific AU-rich element. J Biol Chem 273: 3223-3229, 1998
3. Hadcock JR, Wang H-y, Malbon CC: Agonist-induced destabilization of β-adrenergic receptor mRNA. Attenuation of glucocorticoid-induced up-regulation of β-adrenergic receptors. J Biol Chem 264: 19928-19933, 1989
4. Tholanikunnel BG, Malbon CC: A 20-nucleotide (A + U)-rich element of the β2-adrenergic receptor (β2-AR) mRNA mediates binding to the β2-AR-binding protein and is obligate for agonist-induced destabilization of receptor mRNA. J Biol Chem 272: 11471-11478, 1997
5. Mitchusson KD, Blaxall BC, Pende A, Port JD: Agonist-mediated destabilization of human beta1-adrenergic receptor mRNA: Role of the 3′ untranslated translated region. Biochem Biophys Res Commun 252: 357-362, 1998
6. Kontoyiannis D, Kotlyarov A, Carballo E, Alexopoulou L, Blackshear PJ, Gaestel M, Davis R, Flavell R, Kollias G: Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology. Embo J 20: 3760-3770, 2001
7. Ming XF, Kaiser M, Moroni C: c-jun N-terminal kinase is involved in AUUUA-mediated interleukin-3 mRNA turnover in mast cells. Embo J 17: 6039-6048, 1998
8. Bogoyevitch MA, Andersson MB, Gillespie-Brown J, Clerk A, Glennon PE, Fuller SJ, Sugden PH: Adrenergic receptor stimulation of the mitoggen-activated protein kinase cascade and cardiac hypertrophy. Biochem J 314: 115-121, 1996
9. Zheng M, Zhang SJ, Zhu WZ, Ziman B, Kobilka B, Xiao RP: Beta 2 -adrenergic receptor-induced p38 MAPK activation is mediated by PKA rather than by Gi or Gbeta gamma in adult mouse cardiomyocytes. J Biol Chem 275: 40635-40640, 2000
10. Kirigiti P, Bai Y, Yang YF, Li X, Li B, Brewer G, Machida CA: Agonist-mediated down-regulation of rat beta1-adrenergic receptor transcripts: Role of potential post-transcriptional degradation factors. Mol Pharmacol 60: 1308-1324, 2001
11. Blaxall BC, Pellett AC, Wu SC, Pende A, Port JD: Purification and characterization of beta-adrenergic receptor mRNA-binding proteins. J Biol Chem 275: 4290-4297, 2000
12. Blaxall BC, Pende A, Wu SC, Port JD: Correlation between intrinsic mRNA stability and the affinity of AUF1 (hnRNPD) and HuR for A + U-rich mRNAs. Mol Cell Biochem 232: 1-11, 2002
13. Pende A, Tremmel KD, DeMaria CT, Blaxall BC, Minobe W, Sherman JA, Bisognano J, Bristow MR, Brewer G, Port JD: Regulation of the mRNA-binding protein AUF1 by activation of the β-adrenergic receptor signal transduction pathway. J Biol Chem 271: 8493-8501, 1996
14. Port JD, Huang L-Y, Malbon CC: β-adrenergic agonists that downregulate receptor mRNA up-regulate a Mr 35,000 protein(s) that selectively binds to β-adrenergic receptor mRNAs. J Biol Chem 267: 24103-24108, 1992
15. Tholanikunnel BG, Granneman JG, Malbon CC: The Mr 35,000 β-adrenergic receptor mRNA-binding protein binds transcripts of G-protein-linked receptors which undergo agonist-induced destabilization. J Biol Chem 270: 12787-12793, 1995
16. Blaxall BC, Dwyer-Nield LD, Bauer AK, Bohlmeyer TJ, Malkinson AM, Port JD: Differential expression and localization of the mRNA binding proteins, AU-rich element mRNA binding protein (AUF1) and Hu antigen R (HuR), in neoplastic lung tissue. Mol Carcinogen 28: 76-83, 2000
17. Danner S, Lohse MJ: Cell type-specific regulation of β2-adrenoceptor mRNA by agonists. Eur J Pharmacol 331: 73-78, 1997
18. Izzo N, Seidman CE, Collins S, Colucci WS: α1-Adrenergic receptor mRNA level is regulated by norepinephrine in rabbit aortic smooth muscle cells. Proc Natl Acad Sci USA 87: 6268-6271, 1990
19. Izzo N, Tulenko T, Colucci W: Phorbol esters and norepinephrine destabilize α1b-adrenergic receptor mRNA in vascular smooth muscle cells. J Biol Chem 269: 1705-1710, 1994
20. Tholanikunnel BG, Raymond JR, Malbon CC: Analysis of the AU-rich elements in the 3′-untranslated region of beta 2-adrenergic receptor mRNA by mutagenesis and identification of the homologous AU-rich region from different species. Biochemistry 38: 15564-15572, 1999
21. Li Z, Vaidya VA, Alvaro JD, Iredale PA, Hsu R, Hoffman G, Fitzgerald L, Curran PK, Machida CA, Fishman PH, Duman RS: Protein kinase C-mediated down-regulation of beta 1-adrenergic receptor gene expression in rat C6 glioma cells. Mol Pharmacol 54: 14-21, 1998
22. Zweifach A: Target-cell contact activates a highly selective capacitative calcium entry pathway in cytotoxic T lymphocytes. J Cell Biol 148: 603-614, 2000
23. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450, 1985
24. Hadcock JR, Malbon CC: Down-regulation of β-adrenergic receptors: Agonist-induced reduction in receptor mRNA levels. Proc Natl Acad Sci USA 85: 5021-5025, 1988
25. Pages G, Berra E, Milanini J, Levy AP, Pouyssegur J: Stress-activated protein kinases (JNK and p38/HOG) are essential for vascular endothelial growth factor mRNA stability. J Biol Chem 275: 26484-26491, 2000
26. Mahtani KR, Brook M, Dean JL, Sully G, Saklatvala J, Clark AR: Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability. Mol Cell Biol 21: 6461-6469, 2001
27. Sirenko OI, Lofquist AK, DeMaria CT, Morris JS, Brewer G, Haskill JS: Adhesion-dependent regulation of an A + U-rich element-binding activity associated with AUF1. Mol Cell Biol 17: 3898-3906, 1997
28. Sabri A, Pak E, Alcott SA, Wilson BA, Steinberg SF: Coupling function of endogenous alpha(1)- and beta-adrenergic receptors in mouse cardiomyocytes. Circ Res 86: 1047-1053, 2000
29. Luttrell LM, Hawes BE, van Biesen T, Luttrell DK, Lansing TJ, Lefkowitz RJ: Role of c-Src tyrosine kinase in G protein-coupled receptor- and Gbetagamma subunit-mediated activation of mitogen-activated protein kinases. J Biol Chem 271: 19443-19450, 1996
30. Communal C, Colucci WS, Remondino A, Sawyer DB, Port JD, Wichman SE, Bristow MR, Singh K: Reciprocal modulation of mitogen-activated protein kinases and mitogen-activated protein kinase phosphatase 1 and 2 in failing human myocardium. J Card Fail 8: 86-92, 2002
31. Lemke LE, Bloem LJ, Fouts R, Esterman M, Sandusky G, Vlahos CJ: Decreased p38 MAPK activity in end-stage failing human myocardium: p38 MAPK alpha is the predominant isoform expressed in human heart. J Mol Cell Cardiol 33: 1527-1540, 2001
32. Bueno OF, De Windt LJ, Tymitz KM, Witt SA, Kimball TR, Klevitsky R, Hewett TE, Jones SP, Lefer DJ, Peng CF, Kitsis RN, Molkentin JD: The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. Embo J 19: 6341-6350, 2000
33. Bohm M, Reiger B, Schwinger RH, Erdmann E: cAMP concentrations, cAMP dependent protein kinase activity, and phospholamban in non-failing and failing myocardium. Cardiovasc Res 28: 1713-1719, 1994
34. Ridley SH, Dean JL, Sarsfield SJ, Brook M, Clark AR, Saklatvala J: A p38 MAP kinase inhibitor regulates stability of interleukin-1-induced cyclooxygenase-2 mRNA. FEBS Lett 439: 75-80, 1998
35. Westmark CJ, Malter JS: Up-regulation of nucleolin mRNA and protein in peripheral blood mononuclear cells by extracellular-regulated kinase. J Biol Chem 276: 1119-1126, 2001
36. Ming XF, Stoecklin G, Lu M, Looser R, Moroni C: Parallel and independent regulation of interleukin-3 mRNA turnover by phosphatidylinositol 3-kinase and p38 mitogen-activated protein kinase. Mol Cell Biol 21: 5778-5789, 2001
37. Reunanen N, Li S-P, Ahonen M, Foschi M, Han J, Kahari V-M: Activation of p38alpha MAPK enhances collagenase-1 (matrix metalloproteinase (MMP)-1) and stromelysin-1 (MMP-3) expression by mRNA stabilization. J Biol Chem 277: 32360-32368, 2002
38. Lee NH, Malek RL: Nerve growth factor regulation of m4 muscarinic receptor mRNA stability but not gene transcription requires mitogen-activated protein kinase activity. J Biol Chem 273: 22317-22325, 1998
39. Matsuura H, Sakaue M, Subbaramaiah K, Kamitani H, Eling TE, Dannenberg AJ, Tanabe T, Inoue H, Arata J, Jetten AM: Regulation of cyclooxygenase-2 by interferon gamma and transforming growth factor alpha in normal human epidermal keratinocytes and squamous carcinoma cells. Role of mitogen-activated protein kinases. J Biol Chem 274: 29138-29148, 1999
40. Sheng H, Shao J, Dubois RN: K-Ras-mediated increase in cyclooxygenase 2 mRNA stability involves activation of the protein kinase B1. Cancer Res 61: 2670-2675, 2001
41. Chesley A, Lundberg MS, Asai T, Xiao R-P, Ohtani S, Lakatta EG, Crow MT: The {beta}2-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through Gi-dependent coupling to phosphatidylinositol 3′-kinase. Circ Res 87: 1172-1179, 2000
42. Carballo E, Lai WS, Blackshear PJ: Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 281: 1001-1005, 1998
43. Zhu W, Brauchle MA, Di Padova F, Gram H, New L, Ono K, Downey JS, Han J: Gene suppression by tristetraprolin and release by the p38 pathway. Am J Physiol Lung Cell Mol Physiol 281: L499-L508, 2001